96 related articles for article (PubMed ID: 12481675)
1. Influence of prokinetics on the gastrointestinal transit and residence times of activated charcoal.
Orisakwe OE; Afonne OJ; Ilondu NA; Obi E; Ufearo CS; Agbasi PU; Maduka SO; Orish CN; Orish VN
J Pak Med Assoc; 2002 Aug; 52(8):354-6. PubMed ID: 12481675
[TBL] [Abstract][Full Text] [Related]
2. Effect of saline cathartics on gastrointestinal transit time of activated charcoal.
Orisakwe OE; Ogbonna E
Hum Exp Toxicol; 1993 Sep; 12(5):403-5. PubMed ID: 7902117
[TBL] [Abstract][Full Text] [Related]
3. Effects of magnesium citrate and clidinium bromide on the excretion of activated charcoal in normal subjects.
Vuignier BI; Oderda GM; Gorman RL; Klein-Schwartz W; Watson WA
DICP; 1989 Jan; 23(1):26-9. PubMed ID: 2718479
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal transit times of cathartics combined with charcoal.
Krenzelok EP; Keller R; Stewart RD
Ann Emerg Med; 1985 Dec; 14(12):1152-5. PubMed ID: 4061985
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal transit times of cathartics used with activated charcoal.
Krenzelok EP
Clin Pharm; 1985; 4(4):446-8. PubMed ID: 4042559
[No Abstract] [Full Text] [Related]
6. Saline cathartics and saline cathartics plus activated charcoal as antidotal treatments.
Chin L; Picchioni AL; Gillespie T
Clin Toxicol; 1981 Jul; 18(7):865-71. PubMed ID: 7332642
[TBL] [Abstract][Full Text] [Related]
7. The effects of sorbitol on gastric emptying half-times and small intestinal transit after drug overdose.
Adams BK; Mann MD; Aboo A; Isaacs S; Evans A
Am J Emerg Med; 2006 Jan; 24(1):130-2. PubMed ID: 16338524
[No Abstract] [Full Text] [Related]
8. Are bowel purgatives and prokinetics useful for small-bowel capsule endoscopy? A prospective randomized controlled study.
Postgate A; Tekkis P; Patterson N; Fitzpatrick A; Bassett P; Fraser C
Gastrointest Endosc; 2009 May; 69(6):1120-8. PubMed ID: 19152909
[TBL] [Abstract][Full Text] [Related]
9. Effects of fasting on evaluation of gastrointestinal transit with charcoal meal.
Mittelstadt SW; Hemenway CL; Spruell RD
J Pharmacol Toxicol Methods; 2005; 52(1):154-8. PubMed ID: 15963735
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological comparison of peristaltic effects in rats and mice.
Shaughnessy TK; Larson KJ; Polakowski JS; Martin RL
J Pharmacol Toxicol Methods; 2013; 67(3):129-33. PubMed ID: 23403246
[TBL] [Abstract][Full Text] [Related]
11. Effect of purgatives on antidotal efficacy of oral activated charcoal.
Neuvonen PJ; Olkkola KT
Hum Toxicol; 1986 Jul; 5(4):255-63. PubMed ID: 3733116
[TBL] [Abstract][Full Text] [Related]
12. The influence of codeine, propantheline and metoclopramide on small bowel transit and theophylline absorption from a sustained-release formulation.
Sommers DK; Meyer EC; Van Wyk M; Moncrieff J; Snyman JR; Grimbeek RJ
Br J Clin Pharmacol; 1992 Mar; 33(3):305-8. PubMed ID: 1576052
[TBL] [Abstract][Full Text] [Related]
13. New methods to detect the effect of alteration in gastric pH and intestinal transit by metoclopramide and propantheline using a continuous gastric pH probe and hydrogen breath analysis.
Hughes GS; VanderLugt JT; Bays M; Bohan DF; Francom SF
Methods Find Exp Clin Pharmacol; 1990 Mar; 12(2):155-60. PubMed ID: 2319840
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
Curtis RA; Barone J; Giacona N
Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
[TBL] [Abstract][Full Text] [Related]
15. The influence of arginine-vasopressin on stool output and gastrointestinal transit time in healthy volunteers.
Voderholzer WA; Klauser AG; Mühldorfer BE; Fiedler F; Müller-Lissner SA
Z Gastroenterol; 1995 Apr; 33(4):189-92. PubMed ID: 7793116
[TBL] [Abstract][Full Text] [Related]
16. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption.
Keller RE; Schwab RA; Krenzelok EP
Ann Emerg Med; 1990 Jun; 19(6):654-6. PubMed ID: 2188536
[TBL] [Abstract][Full Text] [Related]
17. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
[TBL] [Abstract][Full Text] [Related]
18. An exploratory study; the therapeutic effects of premixed activated charcoal-sorbitol administration in patients poisoned with organophosphate pesticide.
Moon J; Chun B; Song K
Clin Toxicol (Phila); 2015 Feb; 53(2):119-26. PubMed ID: 25608917
[TBL] [Abstract][Full Text] [Related]
19. Saline catharsis: effect on aspirin bioavailability in combination with activated charcoal.
Sketris IS; Mowry JB; Czajka PA; Anderson WH; Stafford DT
J Clin Pharmacol; 1982 Jan; 22(1):59-64. PubMed ID: 7061727
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of magnesium citrate cathartic in pediatric toxic ingestions.
Sue YJ; Woolf A; Shannon M
Ann Emerg Med; 1994 Oct; 24(4):709-12. PubMed ID: 8092599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
